Pctaire1/Cdk16 promotes skeletal myogenesis by inducing myoblast migration and fusion  by Shimizu, Kouhei et al.
FEBS Letters 588 (2014) 3030–3037journal homepage: www.FEBSLetters .orgPctaire1/Cdk16 promotes skeletal myogenesis by inducing myoblast
migration and fusionhttp://dx.doi.org/10.1016/j.febslet.2014.05.060
0014-5793/ 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Abbreviations: DM, differentiation medium; GM, growth medium; MHC, myosin
heavy chain; MRFs, myogenic regulatory factors
⇑ Corresponding author. Address: Division of Cell-Free Sciences, Proteo-Science
Center, Ehime University, Bunkyo-cho, 3-ban, Matsuyama 790-8577, Japan. Fax:
+81 89 927 9941.
E-mail address: sawasaki@ehime-u.ac.jp (T. Sawasaki).Kouhei Shimizu a, Atsushi Uematsu a, Yuuki Imai b, Tatsuya Sawasaki a,c,⇑
aDivision of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan
bDivision of Integrative Pathophysiology, Proteo-Science Center, Graduate School of Medicine, Ehime University, Toon 791-0295, Japan
c The Venture Business Laboratory, Ehime University, Matsuyama 790-8577, Japana r t i c l e i n f o
Article history:
Received 28 March 2014
Revised 29 May 2014
Accepted 29 May 2014
Available online 12 June 2014
Edited by Angel Nebreda
Keywords:
Pctaire1/Cdk16
Skeletal muscle differentiation
Migration
Process formationa b s t r a c t
The Cdk-related protein kinase Pctaire1/Cdk16 is abundantly expressed in brain, testis and skeletal
muscle. Functional roles of Pctaire1 such as regulation of neuron migration and neurite outgrowth
thus far have been mainly elucidated in the ﬁeld of nervous system development. Although these
regulations based on cytoskeletal rearrangements evoke a possible role of Pctaire1 in the develop-
ment of skeletal muscle, little is known in this regard. In this study, we demonstrated that myogenic
differentiation and subsequent fusion is promoted in Pctaire1 overexpressing cells, and conversely,
is inhibited in the knockdown cells. Furthermore, our ﬁndings suggest that Pctaire1 exerts promy-
ogenic effects by regulating myoblast migration and process formation during skeletal myogenesis.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Myogenic differentiation is an essential process for muscle
growth and homeostasis during embryonic development and in
postnatal life. Myogenesis is accomplished by undergoing multi-
step process accompanied by a complex series of molecular and
morphological changes. After proliferation, followed by cell cycle
withdrawal, mononucleated myoblasts differentiate into elongated
myocytes, then migrate, adhere and fuse to one another to form
multinucleated myotubes, and mature muscle ﬁber in the end
[1–3]. The myogenic program is orchestrated by sequential
activation of myogenic regulatory factors (MRFs), the basic helix–
loop–helix (bHLH) family of transcription factors (Myf5, MyoD,
myogenin and MRF4), which can induce expression of muscle-
speciﬁc genes in concert with transcriptional cofactors such as
Mef2 and E proteins [4–9].
Accumulating evidence suggests that protein kinases function-
ing as substrates for caspase-3 play a key role in regulating differ-
entiation [10–13]. As previously reported, we have identiﬁed 30protein kinases as novel substrates for caspase-3 [14], and investi-
gated their function in skeletal muscle differentiation [13]. In
consequence, we could pick out Pctaire1 kinase as one of the
positive regulators of myogenic differentiation as in the case of
previous report regarding Nek5 [13].
A serine/threonine kinase Pctaire1 (now known as Cdk16) is
one of the atypical members in cyclin-dependent kinase (Cdk) fam-
ily, and has both N- and C-terminal extensions that are divergent
from or absent in other Cdks. These additional domains play
important roles in mediating protein–protein interactions and
were shown to regulate kinase activity [15–17]. Activity of Cdks
is generally regulated by binding to an activating subunit, cyclin.
Unlike conventional cyclin-Cdk interactions, however, not only
the catalytic domain but also domains within the N-terminal
extension of Pctaire1 are required for binding to its activator cyclin
Y [18]. Although Pctaire1 activity has been shown as cell cycle
regulated, it remains uncertain whether Pctaire1 itself is involved
in cell cycle progression in the same way as some other Cdks
[17,19]. Also, an alternative regulatory mechanism has been
proposed to activate and inhibit the kinase activity of Pctaire1
through phosphorylation by Cdk5/p35 and protein kinase A
(PKA), respectively [16,20].
Pctaire1 is ubiquitously expressed in mammalian tissues
including skeletal muscle and is particularly abundant in termi-
nally differentiated cells in brain and testis, and in transformed cell
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cooperates with Cdk5 to initiate a kinase cascade that governs
cytoskeletal rearrangements essential for neuron migration and
neurite outgrowth by the myocardin-related transcription factors
(MRTFs)/serum response factor (Srf) pathway [23]. In human cell
lines, Pctaire1 is phosphorylated at several residues, including
Ser119 and Ser153, which have been shown to be substrates for
PKA in vitro [16,17]. Phosphorylation of S119 and S153 creates
14-3-3 consensus binding motifs, and alanine mutation of both
residues abolishes the binding of Pctaire1 to 14-3-3 in the presence
of active PKA, which also results in the inhibition of neurite out-
growth in Neuro-2A cells [16]. However, the precise role of this
modiﬁcation and 14-3-3 binding remains to be elucidated. In
addition to the function in the nervous system, by generating a
conditional Pctaire1-knockout mouse, Mikolcevic et al. found that
Pctaire1 is essential for the completion of spermatogenesis [17].
Moreover, Pctaire1 has also been reported to be involved in the
regulation of intracellular vesicles and secretion [24,25].
In this study, we focus on the process of myogenesis in which
the role of Pctaire1 remains to be deﬁned though its functions
involved with cytoskeletal rearrangements and exocytosis in ner-
vous system are linked to the process of muscle cell fusion [26].
We report here, Pctaire1 is involved in the promotion of myogenic
differentiation, and fusion by inducing migration and process
formation of myoblasts.
2. Materials and methods
2.1. Antibodies
Antibodies against the following antigens were used: myosin
heavy chain (MHC) (clone MF20: anti-all isoforms, Developmental
Studies Hybridoma Bank, Iowa City, IA), troponin C (sc-20642,
Santa Cruz Biotechnology, Santa Cruz, CA), Pctaire1 (#4852, Cell
Signaling Technology, Beverly, MA), V5 epitope (Invitrogen, Carls-
bad, CA), cleaved caspase-3 (#9664, clone 5A1E, Cell Signaling
Technology) and a-tubulin (clone DM1A, Sigma, St. Louis, MO).
2.2. Plasmid constructs
To construct expression plasmids for mammalian cells, cDNAs
encoding human MyoD1 (RefSeq: NM_002478), human PCTAIRE1
(RefSeq: NM_006201) and mouse Pctaire1 (RefSeq: NM_011049)
were subcloned into vectors (pcDNA3.1/nV5-DEST, pcDNA3.2/V5-
DEST, and pcDNA6.2/N-EmGFP-DEST) (Invitrogen). Mutants of
human PCTAIRE1 were generated by site-directed mutagenesis
using a PrimeSTAR mutagenesis basal kit (Takara Bio Inc., Otsu,
Japan).
2.3. Cell culture and transfection
C2/4 [27] is a subclone of C2C12 mouse myoblast cell line, and
is referred to simply as C2C12 herein. C2C12 cells were maintained
at 37 C in a 5% CO2 incubator in a growth medium (GM) of
Dulbecco’s modiﬁed eagle medium (DMEM) (Nissui, Tokyo, Japan)
supplemented with 10% fetal bovine serum (Sigma, St. Louis, MO),
2 mM L-glutamine (GIBCO, Grand Island, NY), and antibiotics
(100 units/ml penicillin and 100 lg/ml streptomycin) (GIBCO), as
previously reported [13]. Myogenic differentiation of C2C12 myo-
blasts was induced by replacing the GM with a differentiation
medium (DM) that is DMEM with high glucose (Wako, Osaka,
Japan) supplemented with 2% horse serum and penicillin–
streptomycin. Unless otherwise noted, cells were cultured in GM,
and all transfections in this study were performed in a semi-
conﬂuent condition using TransIT-LT1 transfection reagent (Mirus,
Madison, WI) according to the manufacturer’s instruction.2.4. Western blot analysis
All Western blot analyses were performed as described
previously [28]. Brieﬂy, proteins in whole-cell lysates were
separated by SDS–PAGE and transferred onto a PVDF membrane
by electroblotting. After blocking with 5% milk/TBST, the
membrane was probed with a given primary antibody and then
incubated with a horseradish peroxidase (HRP)-conjugated
secondary antibody. The immunoreactive proteins were visualized
using Immobilon Western HRP substrate Luminol Reagent
(Millipore, Bedford, MA) and LAS-4000 mini biomolecular imager
(GE Healthcare, Piscataway, NJ).
2.5. Immunostaining analysis
Cells were ﬁxed with 4% paraformaldehyde in phosphate-
buffered saline (PBS) for 15 min at room temperature, and then
permeabilized with 0.5% Triton X-100 in PBS for 5 min. After block-
ing with 5% calf serum in TBST for 1 h, the cells were incubated
with anti-troponin C antibody, anti-MHC antibody or anti-V5 anti-
body for 1 h at 37 C. The cells were then incubated with Alexa
Fluor 488- and/or 568-conjugated appropriate secondary antibod-
ies (Molecular Probes, Eugene, OR) for 1 h at room temperature.
DAPI staining was carried out concomitantly with the above proce-
dure. Fluorescence images were acquired with the Carl Zeiss
LSM710 confocal laser scanning microscope (Carl Zeiss, Jena,
Germany).
2.6. Real-time quantitative RT-PCR analysis
Total cellular RNA was extracted from C2C12 cells using a QIA-
easy RNA mini kit (Qiagen, Valencia, CA). Extracted total RNA was
subjected to reverse transcription with a Transcriptor First Strand
cDNA Synthesis Kit (Roche, Basel, Schweiz). Real-time qRT-PCR
analysis was performed using a LightCycler 480 Real-time PCR
System (Roche). The following primer sets were designed by the
software of Assay Design Center (Roche): 50-CGCAATCGG
ATCTCTGCT-30 (forward) and 50-CCTCCTTTAGTGCAAATATGGAA-30
(reverse) for Pctaire1; 50-TGAAGATAGTGATTTTATTTTCAAACG-30
(forward) and 50-GACAGACATTGAGAAGTTCTGAGG-30 (reverse)
for Mef2a; and 50-TCTGCCCTCAGTCAGTTGG-30 (forward) and
50-CGTGGTGTGTTGTGGGTATC-30 (reverse) for Mef2c. The values
were normalized to GAPDH (primer set was purchased from
Roche).
2.7. Lentivirus-mediated gene transfer and generation of stable cell
lines
Lentivirus-mediated RNA interference (RNAi) was utilized for
the generation of stable cell lines in which the expression of
Pctaire1 is suppressed, and followed by knockdown analysis. For
this purpose, an HIV-based self-inactivating lentiviral expression
vector (RIKEN BioResource Center, Japan [29]) was slightly modi-
ﬁed by adding a transgene cassette to drive the expression of a
short hairpin RNA (shRNA), and the resulting expression vector
was termed as CSII-CMV-GFP-IRES-Bsd-H1 [30]. In this study, the
following sequences were selected as RNAi targets: 50-GGTAGTTG
CTGGTGAACAGAA-30 (shPctaire1-#1) and 50-GGTTTCCACACTAAGG
CTAGG-30 (shPctaire1-#2), corresponding to the nucleotide
sequences in the 30-UTR of mouse Pctaire1. Negative control
sequences were 50-CAACAAGATGAAGAGCACCAA-30 (non-target
shRNA control, i.e. shNC) and 50-GACTACACAAATCAGCGAT-30
(shLacZ). After construction of the shRNA expression plasmids by
inserting the respective double-stranded oligonucleotides just
downstream of the H1 promoter, lentiviral particles were
generated according to standard transfection protocol. After
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blasticidin S (10 lg/ml, Invitrogen) was generated and used in
subsequent analysis.
2.8. Wound-healing migration assay
Conﬂuent cultures of C2C12 cells were scraped off with a
pipette tip to obtain an acellular area, and GM was then replaced
to remove ﬂoating cells. Phase contrast images of scraped area were
acquired with a CKX41microscope (Olympus, Japan), and the num-
ber of cells that migrated into the area was counted after 6 h.
2.9. Measurement of cell length
Twenty-four hours after transfection with GFP-fusion protein
expression vectors, semi-conﬂuent C2C12 cells were ﬁxed, and
then stained with DAPI. Three ﬁelds were randomly chosen for
acquisition of ﬂuorescent and phase contrast images. Cell length
of GFP-positive cells was then measured on these images using
ZEN imaging software (Carl Zeiss, Jena, Germany). The cell length
in this analysis was deﬁned as a sum of the longest distance from
the center of nucleus to each of two points.
2.10. Statistical analysis
Bar graph data are mean ± S.D. Student’s t-test was used to
determine the signiﬁcance of differences, unless otherwise noted.
Dunnett’s multiple comparison test was used in Fig. 5A. P values
of less than 0.05 were considered statistically signiﬁcant.
2.11. ChIP-seq analysis
ChIP-seq data (GEO accession number GSE44824) for MyoD and
myogenin were used in this study. To ﬁnd the binding peaks, the
data sets (BedGraph format) were visualized by Integrated Genome
Browser (IGB).
3. Results and discussion
3.1. Pctaire1 promotes myogenic differentiation of C2C12 myoblasts
We recently identiﬁed 30 protein kinases including Pctaire1 as
novel substrates for caspase-3 [14], and have investigated the role
of them in skeletal muscle differentiation as in the case of previous
report regarding Nek5 [13]. In consequence of the overexpression
analysis, the promyogenic effect of human Pctaire1 (indicated by
a capital letter in Figure) was found in C2C12 cells as increase in
the expression levels of two myogenic markers: myosin heavy
chain (MHC) and troponin C (Fig. 1A). The equal promyogenic
effect of mouse Pctaire1 that shares 97.6% homology (including
key residues: Ser119, Ser153 and Lys194) with human was also
conﬁrmed by comparison with EGFP-V5 (transfection control)
and MyoD1, a muscle-speciﬁc regulator, which is known to
activate the myogenic differentiation program. Furthermore,
immunostaining showed that most cells expressing exogenous
Pctaire1 were differentiated cells that were positive for troponin
C expression, though the size of myotubes is inferior to that of
MyoD1 (Fig. 1B). In a previous report on another caspase-3
substrate from the same screening, we demonstrated that cleavage
of Nek5 occurs when caspase-3 activity reaches the peak level after
induction of myogenic differentiation in C2C12 cells, and Nek5 or
caspase-3-cleaved Nek5 exerts a promyogenic effect through
up-regulation of caspase-3 activity [13]. Thus, we next investigated
the connection with caspase-3 to gain insight into Pctaire1 func-
tion as a caspase-3 substrate. Although in vitro experiments
revealed that Pctaire1 is cleaved by caspase-3 (SupplementaryFig. S1) [14], the cleavage of Pctaire1 in C2C12 cells was not
observed during myogenic differentiation under the same
condition in which Nek5 cleavage occurs (Fig. 1C). Moreover, no
signiﬁcant difference in the caspase-3 activity was found by
overexpression between EGFP-V5 and Pctaire1 (Fig. 1C). Together,
these ﬁndings indicate that Pctaire1 is able to promote myogenic
differentiation and the function in myogenesis is independent of
caspase-3.
3.2. Up-regulation of Pctaire1 expression occurs during skeletal muscle
differentiation
Pctaire1 is known to be prominently expressed in post-mitotic
cells such as in brain and testis [21,22], and here, we monitored
the expression levels of Pctaire1 to investigate its regulation during
skeletal muscle differentiation. Pctaire1 transcript levels were
increased under conditions of both growth (GM) and differentia-
tion (DM) (Fig. 2A). In GM, differentiation of C2C12 myoblasts
seems to be induced by high cell density-induced cell-cycle
withdrawal. In fact, Mef2a and Mef2c, major cofactors of MRFs,
were induced in GM as well as DM (Supplementary Fig. S2).
Additionally, time-dependent accumulation of Pctaire1 protein is
observed prior to dramatic increase in the levels of MHC protein
(Fig. 2B). These results indicate that skeletal muscle differentiation
is accompanied by up-regulation of Pctaire1. In support of this
notion, publicly available ChIP-seq data (GEO accession number
GSE44824) from C2C12 cells that were differentiated in similar
DM for 60 h revealed binding of MyoD and myogenin in close
proximity to the transcription start site of Pctaire1 (Supplementary
Fig. S3), suggesting the possibility that the myogenic transcription
factors directly regulate Pctaire1 expression during differentiation
of C2C12 cells.
3.3. Suppression of Pctaire1 expression blocks the process of skeletal
myogenesis
Next, to assess whether up-regulation of Pctaire1 is indeed
required for the progression of myogenic differentiation, we estab-
lished C2C12 cells stably expressing short hairpin RNA (shRNA)
targeting mouse Pctaire1 (shPctaire1-#1 and shPctaire1-#2), in
which the levels of Pctaire1 mRNA and protein were signiﬁcantly
decreased compared with cells expressing non-target shRNA
control (shNC) or shLacZ (Fig. 3A and B). We then investigated
the effect of Pctaire1 knockdown on C2C12 differentiation and
found that expression levels of muscle speciﬁc genes including
MHC and troponin C were remarkably reduced in Pctaire1 knock-
down cells (Fig. 3B). Furthermore, MHC immunostaining revealed
that Pctaire1-deﬁcient cells display obvious defects of myogenic
differentiation (Fig. 3C, left panel). To conﬁrm this observation,
we quantiﬁed the degree of myotube formation by counting the
number of nuclei in each knockdown cell. As expected, a large
number of mononucleated cells were noted in Pctaire1 knockdown
cells (Fig. 3C, right graph). Together, these results strongly suggest
that Pctaire1 expression during skeletal muscle differentiation
contributes to the progression of myogenesis.
3.4. Suppression of Pctaire1 expression inhibits myoblast migration
It was recently reported that Pctaire1 plays an important role in
the control of cytoskeletal rearrangements that are essential for
neuronal migration and neurite outgrowth during brain develop-
ment [23,31]. Although these functional roles of Pctaire1 thus far
have been characterized mainly in nervous system, which seems
to be coincidentally associated with the myogenesis because cell
migration and formation of a large F-actin-based protrusion are
fundamental aspects of the process of myoblast fusion [2].
Fig. 1. Pctaire1 exerts a promyogenic effect. C2C12 cells were transfected with the indicated expression vectors. (A and B) After 3 days of transfection, the following
experiments were carried out. (A) The cells were harvested with lysis buffer, and then the lysates were subjected to Western blot analysis using anti-MHC, anti-troponin C,
and anti-V5 antibodies. (B) The transfected cells and differentiated cells were detected by immunostaining with anti-V5 (green) and anti-troponin C (red) antibodies,
respectively (left panel). The percentage of differentiated cells was quantiﬁed in cells expressing the indicated proteins (right graph). Error bars indicate S.D. (N = 3, each N
consists of 100 < cells). A P value < 0.05 was accepted as signiﬁcant. (C) Twenty-four hours after transfection, C2C12 cells were further cultured in fresh growth medium (GM)
or differentiation medium (DM) for 1 day. The cell lysates were subjected to Western blot analysis using anti-V5, anti-cleaved caspase-3, and anti-a-tubulin antibodies.
Fig. 2. The mRNA encoding Pctaire1 is up-regulated during myogenic differentiation. (A) Semi-conﬂuent C2C12 cells were cultured in GM or DM for indicated days, and then
collected. The relative expression levels of Pctaire1 mRNA were determined by real-time quantitative RT-PCR (left panel). The fold changes were displayed in right panel.
GAPDH mRNA was used as an internal control. Error bars indicate S.D. (N = 4). (B) Semi-conﬂuent C2C12 cells were cultured in GM for indicated days. The cell lysates were
subjected to Western blot analysis.
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esis, we primarily examined its effect on myoblast migration using
in vitro wound-healing assay. Myoblast migration into scrapedarea was observed and quantiﬁed by calculating the percentage
of the number of cells that migrated relative to that of cells stably
expressing negative control shRNA (Fig. 4A and B). The result
Fig. 3. Knockdown of Pctaire1 blocks the process of skeletal myogenesis. C2C12 cells stably expressing indicated shRNAs were used in the following experiments. (A) C2C12
cells were cultured in GM or DM for 3 days after conﬂuence, and then collected. The relative expression levels of Pctaire1 mRNA were determined by real-time quantitative
RT-PCR. Error bars indicate S.D. (N = 4). (B) C2C12 cells were cultured in DM for 3 days after conﬂuence. The cell lysates were subjected to Western blot analysis. (C)
Differentiated cells were immunostained with an anti-MHC antibody (red) after 4 days of culture in DM. The number of nuclei in the indicated shRNA-expressing cells (EGFP
positive) was counted by DAPI staining (blue) and grouped into three categories (1, 2–9, and 10<), and then the percentage of that was quantiﬁed (right graph). Error bars
indicate S.D. (N = 3, each N consists of 100 < cells). Statistical analysis: ⁄⁄⁄P < 0.001 vs control (shNC), §§§P < 0.001 vs control (shLacZ), and §§P < 0.005 vs control (shLacZ), at a
group of mononucleated cells.
Fig. 4. Knockdown of Pctaire1 inhibits myoblast migration. Wound-healing migration assay was performed using C2C12 cells stably expressing indicated shRNAs. (A)
Scraped area (between lines on phase contrast images) was observed at different time. (B) The number of cells that migrated into the scraped area was counted after 6 h.
Results were expressed as a percentage of control cells (shNC). Error bars indicate S.D. (N = 4). Statistical analysis: ⁄⁄P < 0.005 vs control (shNC), §§P < 0.005 vs control (shLacZ),
and §P < 0.01 vs control (shLacZ).
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tion of C2C12 cells, suggesting that the involvement of Pctaire1 in
migration is required for the fusion process.
3.5. Pctaire1-induced process formation promotes fusion of skeletal
muscle cell
To gain further insights into how Pctaire1 is involved in
promoting myogenesis, we next asked whether Pctaire1 promotes
process formation like neurite outgrowth in C2C12 cells. For
assessment of morphological change, cells cultured in GM for
1 day after transfection were observed in semi-conﬂuent condi-
tion. The process formation as observed in neuronal cell was
induced in C2C12 cells overexpressing wild-type Pctaire1 (WT)
compared to EGFP-V5 as a control (Fig. 5A). Additionally, their cell
length was measured and quantiﬁed. The same phenotype as WT
was also observed in cells overexpressing kinase-dead mutant
(K194A), suggesting that it is independent of kinase activity of
Pctaire1. As previously reported, two alanine mutants of serine
residue, S119A and S119A/S153A, displayed resistance to the pro-
cess formation compared withWT. We then assessed the efﬁciency
of myotube formation of cells expressing WT-Pctaire1 and its
mutants to investigate whether differences of cell length as shown
in Fig. 5A affect the fusion. Interestingly, the result showed that the
cell length correlated with the percentage of multinucleated cells
(Fig. 5B). Most importantly, the result suggests that cells with anFig. 5. Pctaire1 induces process formation and promotes fusion of skeletal muscle cell. C
transfection, semi-conﬂuent cells were stained with DAPI (blue). Representative images
measured in cells expressing the indicated proteins (right graph). Statistical analysis: Du
indicate mean values. (B) Differentiated cells were immunostained with an anti-MHC anti
indicated proteins (green) was counted by DAPI staining (blue). The fusion index was t
number of nuclei including mononucleated cells (right graph). Error bars indicate S.D. (elongated shape are more able to proceed with the fusion efﬁ-
ciently. This may result from increased opportunity of elongated
cells for contact with cells that are competent to fuse. In addition,
the factor of cell length seems to contribute to the fusion process
rather than differentiation process, because the myogenic differen-
tiation in itself was certainly promoted by S119A and S119A/S153A
mutants compared with those effects on the fusion (Supplemen-
tary Fig. S4).
In human cell lines, Pctaire1 is phosphorylated at several resi-
dues, including Ser119 and Ser153 [16]. Phosphorylation of S119
and S153 is considered to be a key event for binding to 14-3-3 pro-
teins including c and f isoform, since alanine mutation of either
residue is sufﬁcient to abolish its ability to bind [16]. It has been
reported that 14-3-3 isoforms (b, c, f) interact with phosphory-
lated slingshot phosphatases (SSH1, 2 and 3) [32–34], which is
considered to lead to inhibition of SSH activity [33]. Moreover, in
cells stimulated with neuregulin, expression of 14-3-3c prevents
translocation of both SSH1 and coﬁlin to lamellipodia and inhibits
coﬁlin dephosphorylation [33,35]. Coﬁlin, one of F-actin-severing
proteins, plays a crucial role in the regulation of actin polymeriza-
tion accompanied by dynamic changes in the actin cytoskeleton
that provide the mechanical force for migration and neurite
outgrowth [23]. The actin-severing activity of coﬁlin is exerted
through dephosphorylation by SSHs [35,36]. Furthermore, SSH1
dephosphorylates and inactivates LIM kinases (LIMK1 and 2),
which in turn contributes to coﬁlin activation [34]. Thus, 14-3-32C12 cells were transfected with the indicated expression vectors. (A) After 1 day of
were displayed in left panel. Ph denotes Phase contrast image. Cell length was then
nnett’s multiple comparison test, ⁄P < 0.01 vs WT and §P < 0.01 vs EGFP-V5. Red bars
body (red) after 3 days of culture in DM. The number of nuclei in cells expressing the
hen calculated as ratio of the number of nuclei in multinucleated cells to the total
N = 3, each N consists of 100 < cells).
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regulators. Importantly, Pctaire1 is considered to be involved in
the activation of coﬁlin via inactivation of PAK1-LIMK cascade in
neuronal cells [23]. Taking these ﬁndings into account, we
speculate that Pctaire1 competes with SSHs for binding to 14-3-3
proteins, and consequently SSHs can serve as a coﬁlin activator,
which results in the promotion of actin cytoskeletal reorganization
required for the process of myogenesis. To validate our hypothesis,
we examined coﬁlin activity by monitoring its phosphorylation
state. However, no signiﬁcant difference was observed in cells
overexpressing Pctaire1 or stably expressing shPctaire1, compared
with their respective controls (data not shown). This result may
suggest that the effect of Pctaire1 on coﬁlin activity in skeletal
muscle cells is no more than that in nervous system.
Contrary to expectations from our cell-based approach, no
defect of muscle development has been reported in Pctaire1
knockout mice [17]. As previous studies have suggested that a high
degree of functional redundancy among Cdk family members guar-
antees cell cycle progression in mice lacking Cdk2 and in several
Cdks-depleted cells [37–39], other Cdks may complement the
function of Pctaire1 in myogenesis. The most likely candidates
for the redundant function are Pctaire2/3 (Cdk17/18) in which both
domains surrounding Ser119 and Ser153 of Pctaire1 are present.
Importantly, these two domains are unique to the Pctaire subgroup
of Cdk family [17,18]. Pctaire2/3 are also mainly expressed in brain
and/or testis as Pctaire1 [18], however, their functional role
remains poorly characterized. Intriguingly, the expression levels
of Pctaire2/3 in mouse skeletal muscle is relatively low compared
to Pctaire1, though a certain level of Pctaire1–3 transcripts has
been observed in C2C12 mouse skeletal muscle myoblasts
(BioGPS), suggesting the possibility that function of Pctaire1 during
myogenesis is more specialized than that of other Pctaires.
Although further study is required to clarify the precise
molecular mechanism by which Pctaire1 promotes the process of
myogenesis and to deﬁne molecules overlapping the Pctaire1 func-
tion, in summary, our ﬁndings indicate that increased migration
and elongation of cells due to Pctaire1 are important factors in
the effective myogenesis.
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